Replica Analytics (Aetion)

replica-analytics.com
Innovation Type:
Informatics & AI
Cancer Type:
Multiple
Funding Stage:
Exit
Fund:
Prospects
Modeling software to generate synthetic data that protects the individual privacy of data subjects and maintains the statistical properties of real data. This enables easy, fast and effective access to high utility data that is made portable through data simulators

Related news

FACIT portfolio company and leader in synthetic health data, Replica Analytics, acquired by New York-based Aetion

January 7, 2022 - Having recently announced several collaborations following the closing of a financing round with Nina Capital, Replica has significant momentum behind it. Read More

FACIT Features: Replica Analytics, Ottawa-based start-up in health data artificial intelligence

October 13, 2021 – Having recently announced several collaborations following the closing of a financing round with Nina Capital, Replica has significant momentum behind it. Read More

FACIT backs made-in-Ontario data science and medtech innovations through Prospects Oncology Fund

June 23, 2020 – FACIT’s investments strategically address the seed-stage gap experienced by Ontario’s life sciences sector, fueling promising cancer breakthroughs towards a value inflection point and helping local start-ups establish and anchor jobs in the province. Read More

    CONNECT WITH FACIT

    Learn more about how we are driving made-in-Ontario oncology innovations reach the market.